Form 4 for ZDGE Zedge, Inc.
Accepted 2026-09-15 16:51:30 ET · period of report 2026-09-11 · accession 0001193125-26-392060 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-15 16:51 | 2026-09-11 | ZDGE | GIBBER ELLIOT | Dir | P - Purchase | — | +221.8K | 462.0K | +92% | — |
| D | 2026-09-15 16:51 | 2026-09-11 | ZDGE | GIBBER ELLIOT | Dir | P - Purchase | — | +199.7K | 199.7K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class B Common Stock, par value $.01 per share | 2026-09-11 | P | A | 221,843 | — | 461,952 | D | — | — | (F1) The shares of Class B common stock and the warrants to purchase Class B common stock were purchased under the same agreement in a private offering ("Private Placement") at a price of $2.93 per share of Class B common stock and the purchaser received warrants to purchase 90% of the shares of Class B common stock purchased. Each warrant has an exercise price of $3.22 per share, and will become exercisable on the later of: (i) the date which is six months after the closing date of the Private Placement; and (ii) the date of stockholder approval. The warrants expire on September 10, 2036. (F2) Consists of 120,917 fully vested shares of Restricted Stock and 341,035 shares held directly, 221,843 shares of which were purchased in a Private Placement. |
| 2 | Derivative | Warrants (right to buy) | 2026-09-11 | P | A | 199,659 | — | 199,659 | D | $3.22 · — to — | 199,659 Class B Common Stock | (F1) The shares of Class B common stock and the warrants to purchase Class B common stock were purchased under the same agreement in a private offering ("Private Placement") at a price of $2.93 per share of Class B common stock and the purchaser received warrants to purchase 90% of the shares of Class B common stock purchased. Each warrant has an exercise price of $3.22 per share, and will become exercisable on the later of: (i) the date which is six months after the closing date of the Private Placement; and (ii) the date of stockholder approval. The warrants expire on September 10, 2036. (F1) The shares of Class B common stock and the warrants to purchase Class B common stock were purchased under the same agreement in a private offering ("Private Placement") at a price of $2.93 per share of Class B common stock and the purchaser received warrants to purchase 90% of the shares of Class B common stock purchased. Each warrant has an exercise price of $3.22 per share, and will become exercisable on the later of: (i) the date which is six months after the closing date of the Private Placement; and (ii) the date of stockholder approval. The warrants expire on September 10, 2036. (F1) The shares of Class B common stock and the warrants to purchase Class B common stock were purchased under the same agreement in a private offering ("Private Placement") at a price of $2.93 per share of Class B common stock and the purchaser received warrants to purchase 90% of the shares of Class B common stock purchased. Each warrant has an exercise price of $3.22 per share, and will become exercisable on the later of: (i) the date which is six months after the closing date of the Private Placement; and (ii) the date of stockholder approval. The warrants expire on September 10, 2036. |